Commercial Credit Report for Bormioli Pharma Bidco S.p.A.

CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals. Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue. We also offer solutions that can help ease private company financial risk assessment. Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively.

A partial report preview for Bormioli Pharma Bidco S.p.A. is shown below. Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database. To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

	Bormioli Pharma Bidco S.p.A.
Corso Magenta 84
	Milan, 20123 Italy

Business Summary

Bormioli Pharma Bidco S.p.A. was formed by Triton Partners to facilitate its acquisition of the pharmaceutical business unit of Bormioli Rocco S.p.A. The Company manufactures products that comply with the stringent requirements of the pharmaceutical industry (resistance to heat, sunlight, chemicals, reactivity with content, etc.). It has a successful track record of complying with lengthy and rigorous regulatory approval and customer validation processes, which act as barriers to entry. Customers include global pharmaceutical companies, contract manufacturing organizations, and wholesalers.

Scores and Ratings

FRISK^® Score	Z'' Score	PAYCE^® Score	DBT Index	Moody's Rating	Fitch Rating	DBRS Rating
-	-	-	-	Yes	-	-

Financials, News and Filings

Latest Statement	Last Audit	News	SEC Filings	Bankruptcy Filings	Suit & Judgment Filings	Tax Lien Filings
-	-	Yes	-	-	-	-

Industries

SIC Code	Description
6722	Management investment offices, open-end

SITE MAP | ABOUT US | DIRECTORY | STOCK QUOTE: CRMZ | SIGN IN